Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pharmacy Technician Training and Registration Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.
Medicare Improvements for Patients and Providers Act of 2008
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2009 · first_quarter · Q1
HR 1, American Recovery and Reinvestment Act, Title XIII, Health information technology provisions. FDA appropriations FY09 & FY10. Communication re: confirmation of Secretary-Designate Daschle, and Sebelius. Communication to White House Office regarding health care reform. Statement to Senate Finance Committee on workforce and health care reform. Health care reform (no bill #). Letter to Office of the Nat. Coordinator for Health Information Technology regarding Standards Committee appointment.
Communication seeking withdrawal of propxyphene from the market. Communication re: experimental study of consumer reporting of side effects as part of direct-to-consumer advertising. Communication re: evaluation and usefulness of consumer medication information. Communication re: FDA's Sentinal Initiative to monitor medical product safety. Comments on disposal of controlled substances.
Source: Senate LDA
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I, Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation & written testimony before CMS Ambulatory Payment Classification Panel regarding pharmacy overhead. Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 payment rates and 340B Drug Pricing Program. Communications with CMS re:Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Communications with CMS re: billing for pharmacist services in hospital-based anticoagulation clinics.
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation and written testimony before CMS' Ambulatory Payment Classification Panel regarding pharmacy overhead Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 Payment rates. Communications with CMS re: Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Comments to CMS re: e-prescribing exemption for computer generated facsimile transmissions.
Caring for an Aging America Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.
Caring for an Aging America Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.
Poison Center Support, Enhancement, and Awareness Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.
Poison Center Support, Enhancement, and Awareness Act of 2008
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.
Health Care Safety Net Act of 2007
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.
Health Care Safety Net Act of 2007
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R.2642, Iraq War Supplemental Appropriations, additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; nominations to FDA Advisory Committees;MedWatch Partners and electronic data collection; Best Practices for Distribution of Antivirals for Pandemic Influenza: Public Health Impact and Research Recommendations. Communication with FDA concerning the phased removal of propoxyphene from the market.
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Firm: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; Risk Communication Advisory Committee meeting; maintaining HFA designation on labeling. Meeting with FDA Chief of Staff; Communication to FDA re: testimony before joint meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Comments to FDA re concept paper on evaluating proposed drug name submissions. Comments to FDA on content and format labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling; Communication re; nominations to FDA advisory committee
Communication and meetings with CMS staff regarding compendia recognition. Presentation and written testimony before CMS Ambulatory Payment Classification Panel regarding pharmacy overhead. Communication to CMS re: nomination to APC panel. Comments to CMS re: 2010 call letter concerning Part D medication therapy management programs. Communication to CMS regarding payment policy for outpatient anticoagulation services.
Communication to Environmental Protection Agency regarding addition of pharmaceuticals to universal waste rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2008 · fourth_quarter · Q4
S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.
H.R.2642, Iraq War Supplemental Appropriations, additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; nominations to FDA Advisory Committees;MedWatch Partners and electronic data collection; Best Practices for Distribution of Antivirals for Pandemic Influenza: Public Health Impact and Research Recommendations. Communication with FDA concerning the phased removal of propoxyphene from the market.
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I, Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation & written testimony before CMS Ambulatory Payment Classification Panel regarding pharmacy overhead. Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 payment rates and 340B Drug Pricing Program. Communications with CMS re:Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Communications with CMS re: billing for pharmacist services in hospital-based anticoagulation clinics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS via AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2008 · third_quarter · Q3
H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; Risk Communication Advisory Committee meeting; maintaining HFA designation on labeling. Meeting with FDA Chief of Staff; Communication to FDA re: testimony before joint meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Comments to FDA re concept paper on evaluating proposed drug name submissions. Comments to FDA on content and format labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling; Communication re; nominations to FDA advisory committee
S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation and written testimony before CMS' Ambulatory Payment Classification Panel regarding pharmacy overhead Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 Payment rates. Communications with CMS re: Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Comments to CMS re: e-prescribing exemption for computer generated facsimile transmissions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE